Aldehyde dehydrogenase 2 rs671 a/A Genotype is Associated with an Increased Risk of Early Onset Coronary Artery Stenosis
Hui Rao,Xianfang Wang,Yu Luo,Liu Liang,Wei Ye,Xuemin Guo
DOI: https://doi.org/10.2147/ijgm.s461004
IF: 2.145
2024-05-25
International Journal of General Medicine
Abstract:Hui Rao, 1 Xianfang Wang, 2 Yu Luo, 3 Liu Liang, 1 Wei Ye, 1 Xuemin Guo 1 1 Department of Laboratory Medicine, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China; 2 Center for Cardiovascular Diseases, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China; 3 Department of Gynaecology, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China Correspondence: Xuemin Guo, Department of Laboratory Medicine, Meizhou People's Hospital, No. 63 Huangtang Road, Meijiang District, Meizhou, People's Republic of China, Email Background: The role of aldehyde dehydrogenase 2 (ALDH2) in cardiovascular diseases has been gradually studied. However, it is unclear whether ALDH2 polymorphism is associated with the risk of early onset (onset age ≤ 55 years old in men and ≤ 65 years old in women) coronary artery stenosis (CAS). The association between ALDH2 single nucleotide polymorphism (SNP) rs671 and risk in patients with early onset CAS was investigated in this study. Methods: The study included 213 early onset CAS patients and 352 individuals without CAS were set as controls. The ALDH2 rs671 polymorphism was genotyped by polymerase chain reaction (PCR) - microarray. Differences in ALDH2 rs671 genotypes and alleles between patients and controls were compared. Multiple logistic regression analysis was performed after adjusting for gender, body mass index (BMI), smoking history, drinking history, and diabetes mellitus to assess the relationship between ALDH2 rs671 genotypes and early onset CAS risk. Results: The frequency of the ALDH2 rs671 G/G genotype was lower in the early onset CAS patients (43.7% vs 55.3%, p =0.007) than that in the controls. The frequency of the ALDH2 rs671 A allele was higher (32.9% vs 25.0%) than that in the controls ( p =0.005). After adjusting for other confounding factors, multivariate logistic regression showed that ALDH2 rs671 A/A genotype (A/A vs G/G: odds ratio (OR) 2.508, 95% confidence interval (CI): 1.130– 5.569, p =0.024), overweight (BMI≥ 24.0 vs 18.5– 23.9: OR 5.047, 95% CI: 3.275– 7.777, p < 0.001), history of smoking (yes vs no: OR 2.813, 95% CI: 1.595– 4.961, p < 0.001), and diabetes mellitus (yes vs no: OR 2.191, 95% CI: 1.397– 3.437, p =0.001) were the independent risk factors of early onset CAS. Conclusion: In men ≤ 55 years old and women ≤ 65 years old, individuals with ALDH2 rs671 A/A genotype, overweight (BMI ≥ 24.0 kg/m 2 ), smoking history, and diabetes mellitus increased risk of developing CAS. Keywords: aldehyde dehydrogenase 2, gene polymorphism, coronary artery stenosis, early onset Cardiovascular disease (CVD) is one of the major causes of disease burden and even death. 1 Atherosclerosis refers to the deposition of lipid and complex carbohydrate substances in the intima of the arteries, accompanied by the proliferation of fiber tissue and the deposition of calcium salts, which can lead to a large class of cardiovascular diseases. 2,3 Atherosclerotic cardiovascular diseases (ASCVD) include acute coronary syndrome (ACS), myocardial infarction (MI), stable or unstable angina pectoris, ischemic stroke, transient ischemic attack (TIA), and peripheral artery disease (PAD), which increase the risk for cardiovascular events. 4 Atherosclerosis can lead to artery stenosis. 5,6 Coronary artery stenosis (CAS) is the formation of atherosclerotic plaque in the coronary arteries, resulting in the narrowing of the coronary arteries. There is a complex hemodynamic relationship between coronary stenosis and functional myocardial blood supply. In general, CAS often causes myocardial ischemia. 5 The Third Report of the Adult Treatment Panel National Cholesterol Education Program (NCEP-ATP III) guideline defines early onset (premature) coronary heart disease as patients with coronary heart disease whose onset age is ≤55 years in men and ≤65 years in women. 7 Predicting the risk of CAS is important for the prevention and treatment of CAS, especially the early onset CAS. Aldehyde dehydrogenases can metabolize toxic aldehydes into low-toxic carboxylates, thereby reducing cell and tissue damage caused by oxidative stress. 8,9 Among all kinds of aldehyde dehydrogenases, aldehyde dehydrogenase 2 (ALDH2) is particularly important. 10,11 More and more studies have shown that ALDH2 is closely related to cardiovascular diseases such as atherosclerosis, hypertension, and cardiac -Abstract Truncated-
medicine, general & internal